Wedmont Private Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,545
Closed -$26.5K 486
2022
Q4
$26.5K Sell
16,545
-3
-0% -$5 ﹤0.01% 443
2022
Q3
$35K Buy
16,548
+3
+0% +$6 0.01% 368
2022
Q2
$22K Buy
+16,545
New +$24.5K ﹤0.01% 338

Other funds holding PGEN

Wedmont Private Capital's PGEN Position: Q1 2023 in Review

Wedmont Private Capital sold out of Precigen (PGEN) in Q1 2023, closing a stake of 16,545 shares — an estimated $26.5K sold.

Wedmont Private Capital first reported a position in PGEN in Q2 2022 and held it in 3 quarters. The position peaked at $35K in Q3 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • Wedmont Private Capital reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • Wedmont Private Capital sold 16,545 Precigen shares in Q1 2023, an estimated $26.5K.
  • Wedmont Private Capital first reported a position in Precigen in Q2 2022 and held it in 3 quarters.
  • Wedmont Private Capital's Precigen position peaked at $35K in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Wedmont Private Capital's 13F filing for Q1 2023, filed 11 Apr 2023.